A prospective clinical study of non-submerged immediate implants: clinical outcomes and esthetic results.
To evaluate healing of marginal defects in immediate transmucosal implants grafted with anorganic bovine bone, and to assess mucosal and radiographic outcomes 3-4 years following restoration. Thirty immediate transmucosal implants in maxillary anterior extraction sites of 30 patients randomly received BioOss (N=10; BG), BioOss and resorbable collagen membrane (N=10; BG+M) or no graft (N=10; control). Vertical defect height (VDH) reductions of 81.2+/-5%, 70.5+/-17.4% and 68.2+/-16.6%, and horizontal defect depth (HDD) reductions of 71.7+/-34.3%, 81.7+/-33.7% and 55+/-28.4% were observed for BG, BG+M and control groups, respectively, with no significant inter-group differences. Horizontal resorption was significantly greater in control group (48.3+/-9.5%) when compared with BG (15.8+/-16.9%) and BG+M (20+/-21.9%) groups (P=0.000). Ten sites (33.3%) exhibited recession of the mucosa after 6 months; eight (26.7%) had an unsatisfactory esthetic result post-restoration due to recession. Mucosal recession was significantly associated (P=0.032) with buccally positioned implants (HDD 1.1+/-0.3 mm) when compared with lingually positioned implants (HDD 2.3+/-0.6 mm). In 19 patients followed for a mean of 4.0+/-0.7 years, marginal mucosa and bone levels remained stable following restoration. BioOss significantly reduced horizontal resorption of buccal bone. There is a risk of mucosal recession and adverse soft tissue esthetics with immediate implant placement. However, this risk may be reduced by avoiding a buccal position of the implant in the extraction socket.